Become an Anaesthesiologist.

Operation Theatre Technicians (OT Technicians) are the backbone of every surgical team — they set up the sterile field, prepare instrument trays, manage autoclave sterilisation, and assist scrub nurses and surgeons intra-operatively. In India, the role is entered via a B.Sc OT Technology (3-year) or Diploma in OT Technician (2-year) after 12th PCB, and is in high demand at corporate chains (Apollo, Fortis, Max, Manipal), AIIMS and government district hospitals, and standalone surgical centres. Experienced technicians who specialise in Cardiac OT, Neuro OT, or Robotic-assisted surgery earn significantly higher salaries and are actively recruited to GCC countries (Saudi Arabia, UAE, Oman) on tax-free packages.

Pharmacists in India sit at the safety checkpoint between a doctor's prescription and the patient who will actually swallow the tablet — verifying drug dosages, flagging interactions, counselling patients on use, and in many settings being the most accessible healthcare professional in a neighbourhood. The qualification ladder runs D.Pharm (2 years) for retail / community pharmacists, B.Pharm (4 years after Class 12 with PCB / PCM) for hospital and industry roles, and M.Pharm or Pharm.D (6 years, an emerging clinical-pharmacy track) for hospital-clinical, regulatory, and R&D careers. Workplaces split sharply across three lanes: retail / community pharmacy (Apollo Pharmacy, MedPlus, Wellness Forever, neighbourhood chemists), hospital pharmacy (AIIMS, Apollo, Fortis, Manipal — drug-store, IV admixture, oncology day-care, ICU unit-dose), and industry (Sun Pharma, Cipla, Dr. Reddy's, Lupin, Pfizer India, Aurobindo) covering R&D, formulation, regulatory affairs, quality assurance, and medical affairs. State Pharmacy Council registration after qualification is mandatory before practising — and the council under the Pharmacy Act 1948 is a real, audited credential the Drug Inspector can ask for at any moment.

Plastic Surgeons in India operate across two interlocking practices: reconstructive surgery (burn management with split-thickness and full-thickness skin grafts, cleft lip/palate repair using Millard or Tennison-Randall techniques, free flap microsurgery for post-oncological and post-traumatic defects, hand surgery including replantation and tendon reconstruction) and cosmetic/aesthetic surgery (rhinoplasty, blepharoplasty, rhytidectomy, breast augmentation with Baker Grade monitoring, abdominoplasty, liposuction, hair transplant via FUE/FUT). The canonical path is MBBS + MS General Surgery + M.Ch Plastic Surgery (3 years via NEET-SS) at AIIMS, PGI Chandigarh, KEM Mumbai, CMC Vellore, or PGIMER — giving access to both high-volume reconstructive units (burn wards, trauma centres, cancer reconstructive teams at Tata Memorial) and a premium cosmetic practice in metro cities. Aesthetic-only clinics such as Sculpt India, Cocoona, and Anti-Clock have created a parallel high-income private track; senior cosmetic practitioners in Delhi-NCR, Mumbai, and Bengaluru clear ₹2–8 Cr annually.

Siddha doctors in India practise one of the oldest indigenous medical systems — rooted in the Tamil Siddhar tradition, with a 5,000-year lineage attributed to the 18 Siddhars including Agasthiyar and Yugi Munivar. The standard route is BSMS (Bachelor of Siddha Medicine and Surgery, 5.5 years including 1-year compulsory internship) from a CCIM/NCISM-recognised college, admitted through NEET-UG via AYUSH counselling. Practice centres on Mukkutram (Tridosha analogue: Vali/Vata, Azhal/Pitta, Iyam/Kapha) diagnosis through Envagai Thervu (eight-fold examination including Naadi/pulse reading, tongue, eyes, urine, stool, sound, skin, complexion), and prescription of mineral-metallic formulations: Parpam (calcined metals/minerals), Chendooram (red oxide preparations), Mezhugu (wax-based formulations), and Kashayam (decoctions). Thokkanam (classical Siddha massage and manipulative therapy) and Varmam (vital energy-point therapy) are additional procedural skills. The field is highly concentrated in Tamil Nadu — which operates the National Institute of Siddha (NIS Chennai), Arignar Anna Government Hospital of Indian Medicine, and the country's largest state AYUSH Siddha infrastructure — with secondary presence in Kerala, Andhra Pradesh, and among the Tamil diaspora in Sri Lanka and Singapore.

Veterinary doctors in India diagnose, treat, and prevent diseases in animals ranging from companion pets (dogs, cats, exotic birds) to livestock (buffalo, cattle, poultry), wildlife, and aquaculture. The qualifying degree is B.V.Sc & A.H. (Bachelor of Veterinary Science and Animal Husbandry, 5 years including a 6-month internship) from a VCI-recognised college, admitted via NEET-UG. Practice settings span state Animal Husbandry Departments (AHD), private small-animal hospitals in metro cities (Cessna Lifeline, CGS Hospital, Petcura network), dairy cooperative veterinary units (Amul, Nandini, Mother Dairy), poultry integrators (Suguna, Venkateshwara Hatcheries), pharma companies (Zoetis, MSD Animal Health, Elanco), and wildlife / forest departments under the MoEFCC. India's urban pet-care boom — over 32 million pet dogs alone in 2025 — has created a wave of corporate multi-specialty small-animal hospitals in tier-1 and tier-2 cities, bringing surgical specialties (orthopaedics, ophthalmology, oncology) that barely existed 10 years ago.

Nutritionists in India design evidence-based food, nutrient, and lifestyle plans that improve metabolic, hormonal, and chronic-disease outcomes — distinct from clinical dietitians (typically hospital-based RD-IDA-registered roles managing tube feeds, post-surgical, and ICU nutrition) by their stronger lean towards community, corporate-wellness, sports, and private-practice work. Standard routes are B.Sc Food, Nutrition & Dietetics or B.Sc Home Science (Nutrition major) followed by M.Sc Dietetics & Food Service Management or M.Sc Clinical Nutrition; the Indian Dietetic Association RD (Registered Dietitian) credential is the highest-respected India qualification. Practice settings span hospital wards (Apollo, Fortis, Manipal, Max, Medanta), corporate-wellness companies (HealthifyMe, Cure.fit, Truweight, Nourish, Possible, Cult.fit), gym and sports-nutrition consultancies, school and government nutrition programs (POSHAN, ICDS), and increasingly Instagram / YouTube-driven private clinics where a senior nutritionist can run ₹15-50L+ practices on personal-brand reach. The work blends rigorous biochemistry (macronutrient calculation, micronutrient assessment, body-composition tracking, lab-marker interpretation) with sustained behaviour-change coaching — the patient who knows what to eat is not the patient who actually eats it, and the difference is the nutritionist's craft.

Nephrologists are internal medicine super-specialists who manage the entire spectrum of kidney disease: CKD staging and slowing progression with ACEi/ARB/SGLT2i, acute kidney injury in the ICU, dialysis prescription for end-stage renal disease (HD 3×/week or CAPD continuous ambulatory peritoneal dialysis), glomerulonephritis workup and biopsy-guided immunosuppression, transplant medicine from workup to lifelong post-transplant surveillance, and electrolyte and acid-base emergencies. The Indian path is MBBS plus MD General Medicine (3 years) plus DM Nephrology (3 years) — six years of postgraduate training that is among the longest subspecialty pipelines in Indian medicine. Premier seats at AIIMS Delhi, PGIMER Chandigarh, JIPMER, CMC Vellore, KEM Mumbai, KGMU Lucknow, and NIMHANS-affiliated centres. The 2026 India context: CKD burden is estimated at 800 million at-risk individuals given the diabetic and hypertensive population, CAPD penetration is under 3% versus HD, transplant-grade nephrologists are in single-digit supply at many state capitals, and dialysis economics favour hospital-network nephrologists at ₹1.5-3Cr at the apex.

Senior: N/A

Gastroenterologists are physicians who diagnose and treat the entire gastrointestinal tract — from oesophagus to rectum — plus the liver, pancreas, and biliary system, wielding the endoscope as their primary instrument. In India the specialty has become one of the highest-value non-surgical super-specialties: a single ERCP for a biliary stone or an EUS-guided pancreatic biopsy can bill ₹40,000-1,20,000 per case, and a busy interventional gastroenterologist running two lists a day routinely generates ₹6-15 lakh of hospital revenue weekly. The Indian path is MBBS → MD General Medicine (3 years via NEET-PG) → DM Gastroenterology (3 years via NEET-SS), the last being among the top-3 most competitive super-specialty DM seats, with AIIMS Delhi DM Gastroenterology cut-offs frequently in the top 20-50 of the NEET-SS rank. Key practice institutions include AIIMS Delhi, PGIMER Chandigarh, SGPGI Lucknow, CMC Vellore, JIPMER, ILBS Delhi (India's liver transplant hub), Asian Institute of Gastroenterology (AIG) Hyderabad, Apollo Hospitals, Medanta Gurugram, and Fortis. The 2026 demand picture: India carries one of the world's largest burdens of chronic hepatitis B and hepatitis C, non-alcoholic fatty liver disease driven by obesity, and colorectal cancer incidence rising 4% annually — all feeding a specialty whose fully-trained practitioners remain acutely scarce relative to the disease burden.

Senior: N/A

Urologists in India diagnose and surgically treat disorders of the kidney, ureter, bladder, prostate, urethra, and male reproductive tract. The training path is MBBS → MS General Surgery (3 years via NEET-PG) → M.Ch Urology (3 years via NEET-SS), with premier seats at AIIMS Delhi, PGIMER Chandigarh, CMC Vellore, SGPGI Lucknow, and government medical colleges in Mumbai, Kolkata, and Chennai. Workplaces include Apollo Hospitals, Manipal Hospitals, Lilavati Hospital (Mumbai), Medanta, and Fortis, alongside government teaching hospitals and standalone urology centres in tier-1 and tier-2 cities. Indian urology is driven by high stone-disease burden (India has among the world's highest nephrolithiasis prevalence), an ageing BPH population, a rapidly expanding robotic surgery infrastructure, and a severe specialist shortage — fewer than 4,000 urologists for 1.4 billion people.

Senior: N/A

Surgical Oncologists in India perform cancer resection surgeries — breast-conservation and mastectomy, gastrointestinal (esophagus, stomach, colon, rectum, liver, pancreas), gynaecological (ovarian CRS-HIPEC, cervical, uterine), head and neck (total laryngectomy, parotidectomy, neck dissection), and soft-tissue sarcoma excisions — with curative or cytoreductive intent. The Indian training path is MBBS → MS General Surgery (NEET-PG) → M.Ch Surgical Oncology (3 years, NEET-SS), with seats at Tata Memorial Centre Mumbai (HBNI), AIIMS Delhi, RGCI Delhi, PGI Chandigarh, JIPMER, CMC Vellore, and KIDWAI Memorial Institute Bengaluru. Surgical oncologists lead multidisciplinary tumour boards (MDT) for staging and resectability consensus, execute margin-critical procedures where R0 resection is the primary determinant of survival, and are the principal specialists for HIPEC (Hyperthermic Intraperitoneal Chemotherapy) and cytoreductive surgery (CRS) for peritoneal malignancies. India's cancer disease burden (1.4 million new cases/year) and the severe shortage of trained surgical oncologists — fewer than 1,500 practising M.Ch-qualified specialists nationally — make this one of the most undersupplied superspecialities in Indian medicine.

Senior: N/A

Pulmonologists in India manage the full spectrum of respiratory disease — from the TB epidemic (including MDR/XDR-TB under NTEP) and high-burden COPD in smokers and biomass-fuel users, to interventional procedures like flexible bronchoscopy, EBUS (endobronchial ultrasound) for lung-cancer staging, and medical thoracoscopy. The entry path is MBBS → MD General Medicine (3 years via NEET-PG) → DM Pulmonary Medicine (3 years via NEET-SS), totalling nearly a decade of postgraduate training after MBBS. Premier training seats are at AIIMS New Delhi, PGIMER Chandigarh, JIPMER, Asian Institute of Chest Diseases (Hyderabad), PD Hinduja Hospital (Mumbai), Apollo Hospitals (Chennai), and Fortis (multiple). Daily work straddles three environments: high-volume OPD (asthma, COPD GOLD staging, TB follow-up, ILD surveillance), the bronchoscopy suite (BAL, TBLB, EBUS-TBNA), and the medical ICU (ARDS Berlin-criteria management, NIV, invasive ventilation). India's TB burden, rising lung-cancer incidence, post-COVID ILD cohort, and OSA diagnosis gap make pulmonology one of the highest-growth sub-specialities through the 2030s.

Senior: N/A